期刊文献+

陕西汉族人p53 codon 72基因多态性与子宫颈鳞癌易患性的关系:病例对照研究 被引量:2

Relationship between p53 codon 72 polymorphism and liability of squamous cervical cancer in Han population of Shaanxi province: Case-control study
下载PDF
导出
摘要 目的:探讨p5372密码基因多态性与子宫颈鳞癌易患性的关系.方法:在陕西地区汉族妇女中,对子宫颈鳞癌患者33例,健康对照51例进行病例对照研究,用聚合酶链反应法检测p53codon72多态性.结果:p53codon72Arg纯合子、pro纯合子、Arg/pro杂合子在病例组分别是33%,15%,52%;在对照组分别是22%,18%,61%.p53codon72Arg/Arg基因型与Pro/Pro和Arg/Pro两种基因型相比A值=1.80,95%CI=0.37—8.97,差异无统计意义(P〉0.05).结论:p53codon72Arg纯合子可能不增加陕西地区汉族人子宫颈鳞癌易患性. AIM: To explore the relationship between genetic polymorphism of p53 codon 72 and the risk of squamous cervical cancer. METHODS: A case-control study was conducted in Han population of Shaanxi province, involving 33 women with squamous cervical carcinoma as experimental group, and 51 same ethical normal women as control group. DNA extracted from peripheral blood samples and pathologic tissues were examined by PCR with allele specific primers. RESULTS: The rates of arginine (Arg) and proline (Pro) homozygosity and Arg/Pro heterozygosity were 33%, 15% and 52% in experimental group, respectively, 22% , 18% and 61% in control group, respectively. The A of Pro/Pro or Arg/Pro genotype was 1.80 (95% CI = 0.37-8.97 ) compared with Arg/Arg genotype. The A of Pro allele compared with Arg allele was 1. 34 ( 95% CI = 0. 68-2.62 ) . Chi-square analysis showed no significant differences between the 2 groups (P 〉 0.05 ). CONCLUSION : Polymorphism at codon 72 of p53 gene may be not associated with an increased susceptibility to squamous cervical cancer.
出处 《第四军医大学学报》 CAS 北大核心 2006年第16期1499-1501,共3页 Journal of the Fourth Military Medical University
关键词 基因 p53 CODON 72 多态现象 遗传 宫颈肿瘤 鳞状细胞 genes, p53 codon 72 polymorphism, genetic cervix neoplasms carcinoma, squamous cell
  • 相关文献

参考文献15

  • 1杨玲,皇甫小梅,张思维,鲁凤珠,孙秀娣,孙杰,牧人,李连弟,乔友林.中国20世纪70年代与90年代子宫颈癌死亡率及其变化趋势[J].中国医学科学院学报,2003,25(4):386-390. 被引量:84
  • 2Munoz N.Human papillomavirus and cancer:The epidemiological evidence[J].J Clin Virol,2000,19:1-5.
  • 3Storey A,Thomas M,Kalita A,et al.Role of p53 polymorphism in the development of human papillomavirus-associated cancer[J].Nature,1998,393:229-234.
  • 4Beckman G,Birgander R,Sjalander A,et al.Is p53 polymorphism maintained by natural selection[J]? Hum Hered,1994,44:266-270.
  • 5Zehbe I,Voglino G,Wilander E,et al.Codon 72 polymorphism of p53 and its association with cervical cancer[J].Lancet,1999,354:218-219.
  • 6Makni H,Franco EL,Kaiano J,et al.P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer:Effect of inter-laboratory variation[J].Int J Cancer,2000,87:528-533.
  • 7Abba MC,Villaverde LM,Gomez MA,et al.The p53 codon 72 genotypes in HPV infection and cervical disease[J].Eur J Obstet Gynecol Reprod Biol,2003,109:63-66.
  • 8Humbey O,Aubin F,Cairey-Remonnay S,et al.TP53 polymorphism at exon 4 in Caucasian women from eastern France:Lack of correlation with HPV status and grade of cervical precancerous lesions[J].Eur J Obstet Gynecol Reprod Biol,2002,103:60-64.
  • 9郄明蓉,张燕华,吴俊梅.p53 Codon 72多态性与宫颈癌关系的研究[J].华西医科大学学报,2002,33(2):274-275. 被引量:7
  • 10穆丽娜,周学富,丁保国,王如鸿,张作风,姜庆五,俞顺章.p53 condon72基因多态性与胃癌危险度关系——病例对照研究[J].中国癌症杂志,2003,13(1):1-4. 被引量:5

二级参考文献29

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2卫生部肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1979,1..
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Parkin DM, Pisani P, Ferlay J. Global cancer statistics.CA Cancer J Clin, 1999, 49(1):33-64.
  • 5Franeo EL, Duarte-Franco E, Ferenezy A. Cervical cancer:epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 2001, 164(7):1017-1025.
  • 6Zlaang ZF, Parkin DM, Yu SZ, et al. Risk factors for cancer of the cervix in a rural Chinese population. Int J Cancer, 1989, 43:762-767.
  • 7International Agency for Research on Cancer. Monographs on the evaluation of the carcinogenic risks to humans,human papillomaviruses. Vol 64. Lyon: IARC Press, 1995.
  • 8Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papiUomavims in cervical cancer, the IARC multicentric case-control study. Lancet, 2002, 359:1093-1101.
  • 9Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer, 1995, 76(10 Suppl):1888-1901.
  • 10David ME. Screening for cervical cancer. Ann Intern Med, 1990, 113:214-226.

共引文献93

同被引文献10

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部